United States · Bill · HR
H.R. 8025 (96th)
A bill to limit medicare and medicaid payments for certain drugs.
Introduced
26 August 1980
Last action
—
Status
Referred to House Committee on Interstate and Foreign Commerce.
Sponsors
—
Subjects
Discovery layer
Source updated
7 February 2024
Summary
Amends title XVIII (Medicare) and title XIX (Medicaid) of the Social Security Act to prohibit Medicare and Medicaid payments for any new drug or drug similar to a new drug: (1) which has been provisionally approved by the Secretary of Health and Human Services; (2) which may be dispensed only upon prescription; (3) for which the Secretary has issued a notice of a hearing on a proposed order to withdraw approval of such drug because the drug is not effective for all the uses prescribed in its labeling; and (4) for which the Secretary has found no compelling medical need. Continues such prohibition until the Secretary withdraws such proposed order.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Introduced in House
summary · EN · 26 August 1980
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/96th-congress/house-bill/8025
- Open data entity: https://api.congress.gov/v3/bill/96/hr/8025